ARCHIVES

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Controversial Toxicology Protocol Is “Getting The Information We Need;” Additionally Revision Made

March 2, 1984

NeoPharm To Begin Phase III Trial For Glioblastoma

December 26, 2003

‘Dear Dr. Bick’: Letters Reflect Turmoil Over Conflict Of Interest

January 26, 1990

New Criteria For Comprehensive center Status finalized

November 17, 1989

NIH Clinical Trials Committee Adopts Recommendations For Safety Monitoring

June 22, 1979

In Brief: AACR Grants Record Number Of Awards To Young Investigators; Kersey Leads ASBMT

April 24, 1998